JNJ – johnson & johnson (US:NASDAQ)

News

Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs [Yahoo! Finance]
Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs [Reuters]
Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data [Yahoo! Finance]
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ethereum price today: ETH is up 31.98% year to date [USA TODAY]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com